Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (211-220 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|June 12, 2013
Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effectsKatariina M Hutterer, Robert W Hong, Jonathon Lull, et al.
Mabs|June 12, 2013
Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodiesChristophe Passot, Nicolas Azzopardi, Sylvaine Renault, et al.
Mabs|June 15, 2013
Highly efficient selection of epitope specific antibody through competitive yeast display library sortingVinita Puri, Emily Streaker, Ponraj Prabakaran, et al.
Mabs|October 19, 2013
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivoJohannes Trebing, Isabell Lang, Martin Chopra, et al.
Mabs|July 26, 2013
Developability studies before initiation of process development: improving manufacturability of monoclonal antibodiesXiaoyu Yang, Wei Xu, Svetlana Dukleska, et al.
Mabs|July 26, 2013
Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer diseaseLydia Giménez-Llort, Geovanny Rivera-Hernández, Marta Marin-Argany, et al.
Mabs|December 18, 2014
Biosimilars entering the clinic without animal studies. A paradigm shift in the European UnionLeon A G J M van Aerts, Karen De Smet, Gabriele Reichmann, et al.
Mabs|December 18, 2014
Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugarZhongyu Zhu, Boopathy Ramakrishnan, Jinyu Li, et al.
Mabs|December 18, 2014
Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseasesTianlei Ying, Yang Feng, Yanping Wang, et al.
Mabs|December 18, 2014
Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapyDmitrij Hristodorov, Radoslav Mladenov, Hannes Brehm, et al.
Pageof 184

Showing results (211-220 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|June 12, 2013
Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effectsKatariina M Hutterer, Robert W Hong, Jonathon Lull, et al.
Mabs|June 12, 2013
Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodiesChristophe Passot, Nicolas Azzopardi, Sylvaine Renault, et al.
Mabs|June 15, 2013
Highly efficient selection of epitope specific antibody through competitive yeast display library sortingVinita Puri, Emily Streaker, Ponraj Prabakaran, et al.
Mabs|October 19, 2013
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivoJohannes Trebing, Isabell Lang, Martin Chopra, et al.
Mabs|July 26, 2013
Developability studies before initiation of process development: improving manufacturability of monoclonal antibodiesXiaoyu Yang, Wei Xu, Svetlana Dukleska, et al.
Mabs|July 26, 2013
Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer diseaseLydia Giménez-Llort, Geovanny Rivera-Hernández, Marta Marin-Argany, et al.
Mabs|December 18, 2014
Biosimilars entering the clinic without animal studies. A paradigm shift in the European UnionLeon A G J M van Aerts, Karen De Smet, Gabriele Reichmann, et al.
Mabs|December 18, 2014
Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugarZhongyu Zhu, Boopathy Ramakrishnan, Jinyu Li, et al.
Mabs|December 18, 2014
Monomeric IgG1 Fc molecules displaying unique Fc receptor interactions that are exploitable to treat inflammation-mediated diseasesTianlei Ying, Yang Feng, Yanping Wang, et al.
Mabs|December 18, 2014
Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapyDmitrij Hristodorov, Radoslav Mladenov, Hannes Brehm, et al.
Pageof 184